Advertisement

Topics

Dr. Hal Barron appointed Chief Scientific Officer and President, R&D, GSK

11:19 EST 14 Nov 2017 | CentreWatch

GlaxoSmithKline announced that Dr Hal Barron has been appointed Chief Scientific Officer and President, R&D, GSK. He has also been appointed as an Executive Director to the GSK Board. Dr Barron will assume his new role and join the Board on 1 January 2018. Dr Barron is currently President R&D at Calico (California Life Sciences LLC), […]

The post Dr. Hal Barron appointed Chief Scientific Officer and President, R&D, GSK appeared first on CenterWatch News Online.

Original Article: Dr. Hal Barron appointed Chief Scientific Officer and President, R&D, GSK

NEXT ARTICLE

More From BioPortfolio on "Dr. Hal Barron appointed Chief Scientific Officer and President, R&D, GSK"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

GlaxoSmithKline
GlaxoSmithKline is the third largest pharmaceutical company in the world, based on annual sales, which reached $37,134m in 2009. Spread over 100 countries, GSK employs 96,500 people, 13,000 of which are dedicated to research and development of the the ...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...